Igor Lokot | Chief Executive Officer
Double Bond Pharmaceutical A.B.

Igor Lokot, Chief Executive Officer, Double Bond Pharmaceutical A.B.

Igor Lokot, born 1972, Member of the Board in Double Bond Pharmaceutical International ABsince April 2015. Igor has a PhD in Bio-organic Chemistry and a wide experience in drug development. Igor is one of the founders of the pharmaceutical company Oasmia Pharmaceutical AB which is listed on NASDAQ Stockholm.

Appearances:



World Orphan Drug Congress USA 2018 - Conference Day One @ 14:30

Temodex, a locally acting form of temozolomide, for treatment of glioblastoma

back to speakers